Broxyquinoline
![]() | |
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.007.563 |
| Chemical and physical data | |
| Formula | C9H5Br2NO |
| Molar mass | 302.953 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| | |
Broxyquinoline is an antiprotozoal agent.
An association with exercise intolerance has been reported.[1]
References
- ↑ Swain R, Bapna JS (January 1986). "Impairment of exercise tolerance due to broxyquinoline-brobenzoxaldine combination". Human Toxicology. 5 (1): 63–4. doi:10.1177/096032718600500115. PMID 3081430.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

